Literature DB >> 231734

Autonomic neural control of liver glycogen metabolism.

W W Lautt.   

Abstract

Neural and humoral induction of hepatic glycogenolysis occurs via different pathways. Sympathetic nerve stimulation activates alpha adrenergic receptors to produce what is probably a cyclic AMP independent, Ca++ dependent activation of glycogen phosphorylase. Evidence suggests that phosphorylase 'a' is activated by inhibition of phosphorylase phosphatase and perhaps by activation of phosphorylase kinase. Blood borne catecholamines act via beta adrenergic receptors to produce a cyclic AMP dependent activation of phosphorylase kinase. Additionally, hepatic parasympathetic nerves can produce a dramatic shut-down of hepatic glucose output by activation of glycogen synthetase and inhibition of glycogen phosphorylase. The observed minor effect of insulin or intravenous glucose on hepatic glucose uptake compared to the effect of oral doses of glucose suggests that an additional factor other than insulin can produce hepatic glucose uptake: this factor could be, and probably is, the hepatic parasympathetic nerves. The present hypotheses result from a combination and extrapolation of whole animal physiological and in vitro biochemical data.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231734     DOI: 10.1016/0306-9877(79)90096-3

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Peripheral glucose homeostasis: does brain insulin matter?

Authors:  Barry E Levin; Robert S Sherwin
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

2.  Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction.

Authors:  Kalina Duszka; Alexandre Picard; Sandrine Ellero-Simatos; Jiapeng Chen; Marianne Defernez; Eeswari Paramalingam; Anna Pigram; Liviu Vanoaica; Cécile Canlet; Paolo Parini; Arjan Narbad; Hervé Guillou; Bernard Thorens; Walter Wahli
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.